Clinical Trial Update: A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports the completion of the study evaluating Vamikibart for uveitic macular edema. The trial is sponsored by Hoffmann-La Roche…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitic Macular Edema

Drugs mentioned

• Vamikibart (RO7200220)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Uveitic Macular Edema | Phase 3 | Status: COMPLETED